The Norwegian government this Wednesday removed from its vaccination schedule against COVID-19, the drug developed by the Astrazeneca laboratory.
Norwegian Prime Minister Erna Solberg has upheld that decision after its use was suspended in March and the country’s health authorities will recommend its elimination, according to the NRK chain.
On the other hand, Solvber has announced that the use of the Janssen vaccine is still on hold and can only be given to volunteers outside of the vaccine schedule.
Norway has recorded 117,495 cases and a total of 767 deaths from coronavirus since the pandemic began. To date, it has administered 2,021,310 doses of the disease drug and 9.64 percent of its population is immunized.